May 13, 2021
CymaBay Therapeutics Inc. announces that Dennis D. Kim, MD, MBA, is joining the company as Chief Medical Officer.
April 19, 2007
CymaBay Therapeutics raises a $32,000,000 series D round from AllianceBernstein, Alta Partners, KBC, MPM Capital, Novo Ventures, T. Rowe Price, Venrock and Versant Ventures.
Documentaries, videos and podcasts
May 10, 2021
Proven Leader in Building Commercial Organizations to Prepare Markets and Deliver Successful Product Launches Planning for Seladelpar Launch as it Completes Development and Regulatory Submissions
Amirah Al Idrus
November 17, 2020
CymaBay Therapeutics is getting its liver disease drug back on track. The treatment beat placebo at lowering a liver enzyme in patients with primary biliary cholangitis (PBC), a rare, progressive disease that can lead to inflammation and scarring in the liver.
- BiotechnologyBiotechnology can refer to the application of science and technology to living organisms or the use of living organisms, their parts, products or models thereof to solve a problem, produce knowledge or produce goods and services. Biotechnology may involve the alteration of living or non-living materials.
- CompanyA company, abbreviated 'co.', is a legal entity made up of an association of people, be they natural, legal, or a mixture of both, for carrying on a commercial or industrial enterprise.